| AChE | Acetylcholinesterase |
| AD | Alzheimer’s disease |
| ADAM | A disintegrin- and metalloproteinase-family enzymes |
| AICD | APP intracellular domain |
| ALD | Alzheimer’s–like disease |
| APP | Amyloid precursor protein |
| Aβ | Amyloid β |
| ROS | Reactive oxygen species |
| BACE1 | Beta-secretase 1 |
| BBB | Blood brain barrier |
| C83 | 83-amino acid C-terminal fragment |
| C99 | 99-amino acid C terminal fragment |
| CNS | Central nervous system |
| CSF | Cerebrospinal fluid |
| CTF83 | 83-amino acid C-terminal fragment |
| FDG-PET | Fluorodeoxyglucose positron emission tomography |
| GSK-3β | Glycogen synthase kinase-3 beta |
| HCSMA | Hereditary canine spinal muscular atrophy |
| MAP | Microtubule associated protein |
| MCI | Mild cognitive impairment |
| MHC | Major histocompatibility complex |
| MND | Motor neuron disease |
| MRI | Magnetic resonance imaging |
| NFT | Neurofibrillary tangles |
| PET | Positron emission tomography |
| RNS | Reactive nitrogen species |
| sAPPα | Soluble amyloid precursor protein α |
| sAPPβ | Soluble amyloid precursor protein β |
| SP | Senile plaques |
| SR | Scavenger receptors |
| T2D | Type 2 diabetes mellitus |
| T2DM | Type 2 diabetes mellitus |
| TLR | Toll-like receptors |
| TPK | Tau protein kinase |